ICON plc logo

Site Contracts Negotiator II

ICON plc

Blue Bell, PA; Nashville, TN; Hickory, NC; Raleigh, NC; Mt. Pleasant, SC; Cary, NC; Salisbury, NC; Charlotte, NC; Rocky Mount, NC; Long Beach, CA; Knoxville, TN; New York, NY; Rochester, NY; Winston-Salem, NC; Downers Grove, IL; Sherman Oaks, CA; Lawrence, KS; Portland, OR; Cambridge, MA; Boston, MA; Houston, TX; Lexington, KY; Whitesboro, NY; Salt Lake City, UT; Farmingdale, NY; Wilmington, NC; San Antonio, TXRemotePosted 11 days ago
Full TimeMid LevelClinical DevelopmentCRO
Original posting ↗

Summary

As a Site Contracts Negotiator II at ICON, you will independently manage the negotiation and execution of clinical trial agreements and budgets for a range of studies. You will work closely with sites and internal stakeholders to support efficient and compliant study start-up.

Job description

What You Will Do

You will contribute to contract management activities, taking responsibility for your deliverables and working collaboratively. Key responsibilities include:

  • Negotiating site contracts and budgets with investigator sites, within defined parameters and playbooks.
  • Reviewing and adapting contract language to reflect sponsor requirements, local laws, and site feedback.
  • Managing a portfolio of contracts, monitoring cycle times, and proactively addressing barriers to execution.
  • Collaborating with legal, finance, and project teams to resolve contractual questions and ensure alignment.
  • Maintaining accurate records of negotiations, approvals, and executed agreements in relevant systems.
  • Supporting continuous improvement in contract templates, processes, and guidance, and mentoring junior colleagues where appropriate.

Your Profile

You will bring relevant contract management experience, along with the following qualifications and skills. Required qualifications and experience:

  • Bachelor's degree in law, business, life sciences, or a related field, or equivalent experience.
  • Relevant experience in site contracting, contracts administration, or similar roles within CRO, pharma, or healthcare.
  • Good understanding of clinical trial agreements and budget negotiation principles.
  • Strong negotiation, communication, and organizational skills.
  • Ability to manage multiple contracts and timelines, with attention to detail and quality.
  • Proactive, solution-focused mindset with a collaborative approach to stakeholders.

Requirements

  • Bachelor's degree in law, business, life sciences, or a related field, or equivalent experience
  • Relevant experience in site contracting, contracts administration, or similar roles within CRO, pharma, or healthcare
  • Good understanding of clinical trial agreements and budget negotiation principles
  • Strong negotiation, communication, and organizational skills
  • Ability to manage multiple contracts and timelines, with attention to detail and quality
  • Proactive, solution-focused mindset with a collaborative approach to stakeholders

Benefits

  • Competitive base salary
  • Performance related incentives
  • Medical, Dental & Vision
  • Retirement and pension plans
  • Life assurance and disability coverage
  • Employee assistance programmes
  • Wellbeing resources
  • Learning and development opportunities

Company overview

ICON plc is a global leader in clinical research and healthcare intelligence, founded in Dublin, Ireland in 1990. As one of the world's largest contract research organizations (CROs), ICON provides comprehensive outsourced development services to pharmaceutical, biotechnology, and medical device companies worldwide. The company operates in 55 countries with approximately 41,900 employees, offering end-to-end solutions that span the entire product development lifecycle. ICON's service portfolio includes clinical research services, adaptive trials, biosimilars, commercialization and outcomes consulting, medical imaging, laboratory services, and strategic support for traditional and digital health technologies. The company specializes in therapeutic areas such as oncology, cardiovascular diseases, central nervous system disorders, rare diseases, and women's health. With its 2021 acquisition of PRA Health Sciences, ICON significantly expanded its capabilities and market position, becoming a dominant force in the global CRO industry. The company is publicly traded on NASDAQ under the ticker ICLR and reported $8.28 billion in revenue for 2024.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.